ArticlePharmaceutics2018

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification.

Sabine Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.